Caplight Directory>Companies>RNAGene Inc.-preview>Rnagene


RNAGene Inc.

RNAGene Inc.

Private
SeoulHealthcare & Life Scienceshttp://rnagene.com/

Last Round

Series A

Extension

Oct 8, 2024

Total Funding Raised

$1.47M

Company Overview

RNAGene Inc. is a biotechnology company that develops mRNA-based therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

mRNA therapeuticsmRNA synthesismRNA vaccinesmRNA platformlipid nanoparticlesLNP formulationmRNA CDMOcustom mRNA synthesisbiotech CROdrug discoverymRNA stabilizationinfectious disease therapeuticsrare disease therapeuticsRPiCSCALUTIS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNAGene Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RNAGene Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 8, 2024
View all Funding Rounds

RNAGene Inc. Investors

Notable investors and investment history

InvestorRounds
Angel LoungeSeries A Extension
AI Angel ClubSeries A Extension
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 8, 2024

    $1.47M round from AI Angel Club and Angel Lounge.

View all signals

RNAGene Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RNAGene Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RNAGene Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2018
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.